PKC‐β/Alox5 axis activation promotes Bcr‐Abl‐independent TKI‐resistance in chronic myeloid leukemia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PKC‐β/Alox5 axis activation promotes Bcr‐Abl‐independent TKI‐resistance in chronic myeloid leukemia
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-02-11
DOI
10.1002/jcp.30301
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low-dose staurosporine selectively reverses BCR-ABL-independent IM resistance through PKC-α-mediated G2/M phase arrest in chronic myeloid leukaemia
- (2019) Dan Ma et al. Artificial Cells Nanomedicine and Biotechnology
- Increased Serine and One-Carbon Pathway Metabolism by PKCλ/ι Deficiency Promotes Neuroendocrine Prostate Cancer
- (2019) Miguel Reina-Campos et al. CANCER CELL
- Antitumor efficacy of arsenic/interferon in preclinical models of chronic myeloid leukemia resistant to tyrosine kinase inhibitors
- (2019) Rabab El Eit et al. CANCER
- Overexpression of tensin homolog deleted on chromosome ten (PTEN) by ciglitazone sensitizes doxorubicin‐resistance leukemia cancer cells to treatment
- (2019) Samira Mashayekhi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition
- (2017) Rebecca Mitchell et al. JNCI-Journal of the National Cancer Institute
- Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition
- (2017) Rebecca Mitchell et al. JNCI-Journal of the National Cancer Institute
- Mechanisms of Primary and Secondary Resistance to Imatinib in Chronic Myeloid Leukemia
- (2017) Alfonso Quintás-Cardama et al. Cancer Control
- Protein Kinase C Enzymes in the Hematopoietic and Immune Systems
- (2016) Amnon Altman et al. Annual Review of Immunology
- PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment
- (2016) Angel Guerrero-Zotano et al. CANCER AND METASTASIS REVIEWS
- Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination
- (2016) Jason S. L. Yu et al. DEVELOPMENT
- Modulation of leukotriene signaling inhibiting cell growth in chronic myeloid leukemia
- (2016) Elham Yektaei-Karin et al. LEUKEMIA & LYMPHOMA
- Downregulation of HO-1 promoted apoptosis induced by decitabine via increasing p15 INK4B promoter demethylation in myelodysplastic syndrome
- (2015) D Ma et al. GENE THERAPY
- Induction of Heme Oxygenase-1 by Na+-H+Exchanger 1 Protein Plays a Crucial Role in Imatinib-resistant Chronic Myeloid Leukemia Cells
- (2015) Dan Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The tumor suppressor PTEN has a critical role in antiviral innate immunity
- (2015) Shun Li et al. NATURE IMMUNOLOGY
- PKC- as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL
- (2014) D. El-Gamal et al. BLOOD
- 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell-like Cells in Acute Myeloid Leukemia
- (2014) J. Roos et al. CANCER RESEARCH
- A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia
- (2014) L. Ma et al. Science Translational Medicine
- Role of calcium-dependent protein kinases in chronic myeloid leukemia: combined effects of PKC and BCR-ABL signaling on cellular alterations during leukemia development
- (2014) Andre Mencalha et al. OncoTargets and Therapy
- Atypical Protein Kinase Cι as a human oncogene and therapeutic target
- (2013) Peter J. Parker et al. BIOCHEMICAL PHARMACOLOGY
- Cell cycle arrest or survival signaling through αv integrins, activation of PKC and ERK1/2 lead to anoikis resistance of ovarian cancer spheroids
- (2013) Ludovic Carduner et al. EXPERIMENTAL CELL RESEARCH
- Molecular and cellular bases of chronic myeloid leukemia
- (2010) Yaoyu Chen et al. Protein & Cell
- Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia
- (2009) Yaoyu Chen et al. NATURE GENETICS
- Acadesine Kills Chronic Myelogenous Leukemia (CML) Cells through PKC-Dependent Induction of Autophagic Cell Death
- (2009) Guillaume Robert et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started